Larson Financial Group LLC Iovance Biotherapeutics, Inc. Transaction History

Larson Financial Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$7.59 - $17.47 $7,590 - $17,470	1,000 New	1,000 $14,000
Q1 2022 May 05, 2022	BUY	$12.38 - $19.1 $14,856 - $22,920	1,200 New	1,200 $20,000
Q4 2021 Feb 03, 2022	SELL	$16.55 - $27.63 $13,240 - $22,104	-800 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$27.75 - $36.3 $22,200 - $29,039	800 New	800 $26,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Larson Financial Group LLC with notifications on news.